Vast Therapeutics
  • Home
  • About
    • Our Team
    • Scientific Advisory Board
  • Technology
    • Pipeline
    • NO Prodrugs
    • Posters/Presentations
  • Patients
    • Bronchiectasis
    • NTM Lung Disease
    • Cystic Fibrosis
    • Other Targets
  • News
  • Contact
  • Our Team

About

Company Overview

Vast is a clinical stage, airway immunology company focused on breaking the vicious cycle of infection and chronic inflammation in respiratory diseases.  We live at the air-liquid interface in efforts to advance new treatments for some of the world’s most challenging drug-resistant microbial infections.

The Vast technology platform begins with harnessing the unmatched antimicrobial activity of nitric oxide in the form of stable prodrugs.  When combined with inhalation formulation expertise and proprietary chemistry for delivering drug candidates to the lungs, the result is aerosolized therapies targeting the specific needs of individual patient populations.   

Nitric oxide is an endogenous molecule that plays a vital role in the natural immune system response to microbial pathogens.  Taking cues from human physiology, our nitric oxide based “antibiotic alternative” compounds are not susceptible to antimicrobial resistance mechanisms common to traditional antibiotics. 
​
Vast Therapeutics logo - white

Address

615 Davis Drive, Suite 800
​Morrisville, NC 27560

Contact Us

info@vasttherapeutics.com

Sector

Biopharmaceutical

Industry

​Biotechnology

    Sign Up for Email Alerts

Submit
​Forward-Looking Statement | Privacy | Terms of Use
​Copyright © 2022 Vast Therapeutics - All Rights Reserved
Picture
  • Home
  • About
    • Our Team
    • Scientific Advisory Board
  • Technology
    • Pipeline
    • NO Prodrugs
    • Posters/Presentations
  • Patients
    • Bronchiectasis
    • NTM Lung Disease
    • Cystic Fibrosis
    • Other Targets
  • News
  • Contact
  • Our Team